AstraZeneca may face a fine of up to $8 million in China over suspected unpaid taxes related to the import of its breast ...

AstraZeneca on Tuesday said it may face a fine of up to $8 million over suspected unpaid import taxes in China as the ...

On Feb. 7, AstraZeneca announced it received a Notice of Transfer to the Prosecutor and an Appraisal Opinion from the ...

Akeso's first overall survival readout for its Keytruda challenger caused a violent market reaction. AstraZeneca disclosed ...

The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of ...

Beijing R&D centre In March 2025, AstraZeneca announced it will establish its sixth global strategic R&D centre, to be located in Beijing, China. It will be AstraZeneca's second R&D centre in ...

Despite AstraZeneca’s falling share price today, this writer believes the London-listed pharmaceutical giant could be worth a ...

China has exempted some U.S. imports from its 125% tariffs and is asking firms to identify critical goods they need levy-free ...

AstraZeneca is scheduled to report results for the first quarter on Tuesday. Here is what you need to know.

Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...

AstraZeneca is contending with headwinds in its two biggest markets, the US and China - scandals in China, possible US tariffs on pharmaceutical products, and a trade war between Beijing and ...